Advanced

Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference

Wahren, Britta; Biswas, Priscilla; Borggren, Marie LU ; Coleman, Adam; Da Costa, Kelly; De Haes, Winni; Dieltjens, Tessa; Dispinseri, Stefania; Grupping, Katrijn and Hallengard, David, et al. (2010) In Journal of Translational Medicine 8.
Abstract
EUROPRISE is a Network of Excellence sponsored from 2007 to 2011 by the European Commission within the 6th Framework Program. The Network encompasses a wide portfolio of activities ranging from an integrated research program in the field of HIV vaccines and microbicides to training, dissemination and advocacy. The research program covers the whole pipeline of vaccine and microbicide development from discovery to early clinical trials. The Network is composed of 58 partners representing more than 65 institutions from 13 European countries; it also includes three major pharmaceutical companies (GlaxoSmithKline, Novartis and Sanofi-Pasteur) involved in HIV microbicide and vaccine research. The Network displays a dedicated and informative web... (More)
EUROPRISE is a Network of Excellence sponsored from 2007 to 2011 by the European Commission within the 6th Framework Program. The Network encompasses a wide portfolio of activities ranging from an integrated research program in the field of HIV vaccines and microbicides to training, dissemination and advocacy. The research program covers the whole pipeline of vaccine and microbicide development from discovery to early clinical trials. The Network is composed of 58 partners representing more than 65 institutions from 13 European countries; it also includes three major pharmaceutical companies (GlaxoSmithKline, Novartis and Sanofi-Pasteur) involved in HIV microbicide and vaccine research. The Network displays a dedicated and informative web page: http://www.europrise.org. Finally, a distinguishing trait of EUROPRISE is its PhD School of students from across Europe, a unique example in the world of science aimed at spreading excellence through training. EUROPRISE held its second annual conference in Budapest in November, 2009. The conference had 143 participants and their presentations covered aspects of vaccine and microbicide research, development and discovery. Since training is a major task of the Network, the students of the EUROPRISE PhD program summarized certain presentations and their view of the conference in this paper. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Translational Medicine
volume
8
publisher
BioMed Central
external identifiers
  • wos:000282449400001
  • scopus:77954884081
ISSN
1479-5876
DOI
10.1186/1479-5876-8-72
language
English
LU publication?
yes
id
50de0be0-90f9-4a52-b754-71c984fa24df (old id 1727071)
date added to LUP
2010-12-01 13:37:46
date last changed
2018-05-29 10:39:59
@article{50de0be0-90f9-4a52-b754-71c984fa24df,
  abstract     = {EUROPRISE is a Network of Excellence sponsored from 2007 to 2011 by the European Commission within the 6th Framework Program. The Network encompasses a wide portfolio of activities ranging from an integrated research program in the field of HIV vaccines and microbicides to training, dissemination and advocacy. The research program covers the whole pipeline of vaccine and microbicide development from discovery to early clinical trials. The Network is composed of 58 partners representing more than 65 institutions from 13 European countries; it also includes three major pharmaceutical companies (GlaxoSmithKline, Novartis and Sanofi-Pasteur) involved in HIV microbicide and vaccine research. The Network displays a dedicated and informative web page: http://www.europrise.org. Finally, a distinguishing trait of EUROPRISE is its PhD School of students from across Europe, a unique example in the world of science aimed at spreading excellence through training. EUROPRISE held its second annual conference in Budapest in November, 2009. The conference had 143 participants and their presentations covered aspects of vaccine and microbicide research, development and discovery. Since training is a major task of the Network, the students of the EUROPRISE PhD program summarized certain presentations and their view of the conference in this paper.},
  author       = {Wahren, Britta and Biswas, Priscilla and Borggren, Marie and Coleman, Adam and Da Costa, Kelly and De Haes, Winni and Dieltjens, Tessa and Dispinseri, Stefania and Grupping, Katrijn and Hallengard, David and Hornig, Julia and Klein, Katja and Mainetti, Lara and Palma, Paolo and Reudelsterz, Marc and Seifried, Janna and Selhorst, Philippe and Skold, Annette and van Gils, Marit J. and Weber, Caroline and Shattock, Robin and Scarlatti, Gabriella},
  issn         = {1479-5876},
  language     = {eng},
  publisher    = {BioMed Central},
  series       = {Journal of Translational Medicine},
  title        = {Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference},
  url          = {http://dx.doi.org/10.1186/1479-5876-8-72},
  volume       = {8},
  year         = {2010},
}